Proterol

Procaterol HCl

Remission of various symptoms caused by resp obstructive disturbance in bronchial asthma, acute, chronic & asthmatoid bronchitis, pulmonary emphysema.

Adult 10 mL. Childn ≥6 yr 5 mL, <6 yr 0.25 mL/kg. Given once daily before bed or twice daily (in the morning & before bed).

Hypersensitivity.

Discontinue if hypersensitivity occurs; 12 hr prior to allergen tests; desired therapeutic effect is not achieved at recommended doses. Patients w/ hyperthyroidism (may be exacerbated), heart disease (may cause palpitation, arrhythmia, exacerbation & other symptoms), HTN (may further increase BP) & DM (may be exacerbated). Do not exceed recommended dosage. Used only as an additional therapy, not a substitute for inhaled corticosteroids & other anti-inflammatory agents in bronchial asthma long-term management. May develop acute asthma episodes during long term use. Pregnancy. Interrupt nursing prior to treatment. Childn. Low birth wt infants & neonates. Elderly.

Shock or anaphylactoid reaction; significant decrease in serum K levels. Palpitations, tachycardia; tremor, headache; nausea, vomiting; skin rash. Facial flushing; dizziness, insomnia, limb numbness; dry mouth, gastric discomfort; generalized malaise, weakness, nasal obstruction, tinnitus.

May cause arrhythmias or cardiac arrest w/ catecholamines (eg, epinephrine & isoproterenol). May aggravate hypokalemia & CV adverse reactions (eg, tachycardia, arrhythmias) w/ xanthine derivatives (eg, theophylline, aminophylline hydrate & diprophylline). May decrease serum K levels resulting in arrhythmias w/ corticosteroids (eg, betamethasone, prednisolone & hydrocortisone Na succinate) or diuretics (eg, furosemide).

Antiasthmatic & COPD Preparations

R03CC08 - procaterol ; Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.

G